Literature DB >> 7667316

Contrasting roles for Myc and Mad proteins in cellular growth and differentiation.

L Chin1, N Schreiber-Agus, I Pellicer, K Chen, H W Lee, M Dudast, C Cordon-Cardo, R A DePinho.   

Abstract

The positive effects of Myc on cellular growth and gene expression are antagonized by activities of another member of the Myc superfamily, Mad. Characterization of the mouse homolog of human mad on the structural level revealed that domains shown previously to be required in the human protein for anti-Myc repression, sequence-specific DNA-binding activity, and dimerization with its partner Max are highly conserved. Conservation is also evident on the biological level in that both human and mouse mad can antagonize the ability of c-myc to cooperate with ras in the malignant transformation of cultured cells. An analysis of c-myc and mad gene expression in the developing mouse showed contrasting patterns with respect to tissue distribution and developmental stage. Regional differences in expression were more striking on the cellular level, particularly in the mouse and human gastrointestinal system, wherein c-Myc protein was readily detected in immature proliferating cells at the base of the colonic crypts, while Mad protein distribution was restricted to the postmitotic differentiated cells in the apex of the crypts. An increasing gradient of Mad was also evident in the more differentiated subcorneal layers of the stratified squamous epithelium of the skin. Together, these observations support the view that both downregulation of Myc and accumulation of Mad may be necessary for progression of precursor cells to a growth-arrested, terminally differentiated state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667316      PMCID: PMC41182          DOI: 10.1073/pnas.92.18.8488

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription.

Authors:  G J Kato; J Barrett; M Villa-Garcia; C V Dang
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo.

Authors:  K M Downs; G R Martin; J M Bishop
Journal:  Genes Dev       Date:  1989-06       Impact factor: 11.361

3.  Cloning and nucleotide sequence analysis of the Saccharomyces cerevisiae RAD4 gene required for excision repair of UV-damaged DNA.

Authors:  R D Gietz; S Prakash
Journal:  Gene       Date:  1988-12-30       Impact factor: 3.688

4.  c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells.

Authors:  E V Prochownik; J Kukowska; C Rodgers
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

5.  Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate.

Authors:  H M Lachman; G H Cheng; A I Skoultchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Cell migration pathway in the intestinal epithelium: an in situ marker system using mouse aggregation chimeras.

Authors:  G H Schmidt; M M Wilkinson; B A Ponder
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

7.  Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos.

Authors:  P Schmid; W A Schulz; H Hameister
Journal:  Science       Date:  1989-01-13       Impact factor: 47.728

8.  Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells.

Authors:  J Chen; T Willingham; L R Margraf; N Schreiber-Agus; R A DePinho; P D Nisen
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

9.  Differential expression of myc family genes during murine development.

Authors:  K A Zimmerman; G D Yancopoulos; R G Collum; R K Smith; N E Kohl; K A Denis; M M Nau; O N Witte; D Toran-Allerand; C E Gee
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

10.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
View more
  25 in total

1.  Mad1 function is regulated through elements within the carboxy terminus.

Authors:  G Barrera-Hernandez; C M Cultraro; S Pianetti; S Segal
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Essential role for Max in early embryonic growth and development.

Authors:  H Shen-Li; R C O'Hagan; H Hou; J W Horner; H W Lee; R A DePinho
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

3.  MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network.

Authors:  A N Billin; A L Eilers; K L Coulter; J S Logan; D E Ayer
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  c-Myc promotes differentiation of human epidermal stem cells.

Authors:  A Gandarillas; F M Watt
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

5.  Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis.

Authors:  C Quéva; G A McArthur; B M Iritani; R N Eisenman
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

6.  Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice.

Authors:  Andrew B Lassman; Chengkai Dai; Gregory N Fuller; Andrew J Vickers; Eric C Holland
Journal:  Neuron Glia Biol       Date:  2004-05

7.  c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene.

Authors:  A J Walhout; J M Gubbels; R Bernards; P C van der Vliet; H T Timmers
Journal:  Nucleic Acids Res       Date:  1997-04-15       Impact factor: 16.971

8.  Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation.

Authors:  K P Foley; G A McArthur; C Quéva; P J Hurlin; P Soriano; R N Eisenman
Journal:  EMBO J       Date:  1998-02-02       Impact factor: 11.598

9.  The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice.

Authors:  T Shinagawa; H D Dong; M Xu; T Maekawa; S Ishii
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

10.  Mad proteins contain a dominant transcription repression domain.

Authors:  D E Ayer; C D Laherty; Q A Lawrence; A P Armstrong; R N Eisenman
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.